Digital Health: Page 3


  • Image attribution tooltip

    Shutterstock.com/Tonia Twichell

    Sponsored by GE Healthcare

    Post call: How a pandemic transformed healthcare for the future

    From the frontlines of 2020 to the forefront of the future, what worked, what didn’t, and what must be prioritized today to thrive tomorrow. 

    Aug. 23, 2021
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    Abiomed leads latest FDA breakthrough designations for heart disease devices

    The agency awarded the breakthrough privileges to Abiomed's Impella ECP, which the company contends is the world's smallest heart pump and could provide critical hemodynamic support to coronary artery disease patients.

    By Aug. 19, 2021
  • Image attribution tooltip
    Adeline Kon/MedTech Dive
    Deep Dive

    Predicting the future of healthcare: 10 takeaways from HIMSS21

    Along with "guarded optimism" on the current state of the pandemic, some 19,000 on-site attendees in Las Vegas mulled what's next for AI, telehealth, cybersecurity, mental health and more.

    By Rebecca Pifer , Hailey Mensik • Aug. 17, 2021
  • Image attribution tooltip
    Permission granted by Royal Philips
    Q&A

    Q&A with Philips' head of connected healthcare on new products, hospital tech adoption in the COVID-19 era

    Roy Jakobs caught up with Healthcare Dive virtually on the sidelines of HIMSS21 to chat about provider burden, interoperability and new products.

    By Rebecca Pifer • Aug. 12, 2021
  • Image attribution tooltip
    Fotolia
    Opinion

    Digital therapeutics — a double-edged sword?

    Aloha McBride, EY's global health leader, argues that algorithms need to be regularly audited and screened for bias and discrepancies, while clinicians play a vital role in explaining the key features of apps and patient privacy risks.

    By Aloha McBride • Aug. 10, 2021
  • Deep Dive

    Diabetes tech companies set sights on Type 2 patients as user numbers climb

    With patients flocking to CGMs and insulin pumps over the past several years, companies like Dexcom, Insulet and Tandem are looking to further expand. 

    By Aug. 9, 2021
  • Image attribution tooltip
    Adeline Kon/MedTech Dive

    5 must-watch panels at an unprecedented HIMSS21

    Masks and proof of vaccination will be required on the ground in Las Vegas, and a corresponding digital event will also take place.

    By Rebecca Pifer • Aug. 9, 2021
  • Image attribution tooltip
    Permission granted by iRhythm

    iRhythm doesn't expect 2022 CMS pricing. 'It may take some time.'

    Amid a challenging 2021, the cardiac monitoring player beat Wall Street revenue expectations. However, Medicare pricing uncertainty is still hanging over its future.

    By Aug. 6, 2021
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    Digital health, heart disease devices feature in latest FDA breakthrough designations

    Philips, Endologix and several smaller companies in recent weeks won the regulatory privilege, giving them speedier review of products that may provide more effective treatments for life-threatening conditions.

    By Aug. 2, 2021
  • Image attribution tooltip
    Adobe Stock

    Hillrom reverses course, will finalize $375M BardyDx acquisition

    The decision ends a months-long fight by Hillrom to back out of the buy due to substantially reduced Medicare rate cuts for long-term cardiac monitoring. Hillrom expects the deal to close in the coming weeks.

    By Aug. 2, 2021
  • GE Healthcare's COVID-19 recovery continues with double-digit growth in imaging, ultrasound

    Second-quarter results reflect the return of elective procedures to pre-pandemic levels. A standout was its pharmaceutical diagnostics business which saw orders grow nearly 50% organically year over year.   

    By July 27, 2021
  • Philips recalls 2021

    Philips Q2 hit from sleep apnea, ventilator recall overshadows pandemic recovery

    CEO Frans van Houten downplayed the potential of a significant impact on Philips' business. But, Baird analysts contend the company could lose about $800 million in the 12-month repair/replace cycle, with ResMed benefiting.

    By July 26, 2021
  • Image attribution tooltip
    Fotolia

    Health tracking tech revenue to reach $13B this year amid sustained consumer demand

    Devices like blood glucose trackers, smart thermometers and pulse oximeters are a small but growing slice of the larger consumer tech market, according to the Consumer Technology Association.

    By Rebecca Pifer • July 19, 2021
  • Image attribution tooltip
    Courtesy of Dexcom, Nick Jonas Super Bowl kit

    Dexcom wins FDA nod for real-time APIs, allowing third-party developers access to CGM data

    Teladoc Health's Livongo and smartwatch maker Garmin are in the testing and development phase, Dexcom said. The clearance comes as FDA is working to address the devices backlog created by the pandemic.

    By July 16, 2021
  • Image attribution tooltip

    iStock

    CMS proposes extension of Medicare telehealth coverage

    Provider groups are not happy with the payment adjustment in the rule — a 3.75% reduction to the conversion factor due to budget neutrality requirements — and will likely seek congressional intervention.

    By Shannon Muchmore • July 14, 2021
  • CMS again passes on national pricing for long-term cardiac monitoring, dramatically reduced rates remain

    The Physician Fee Schedule proposal continues the seven-month pricing saga that has hung over the cardiac wearables sub-market. Companies like iRhythm now have few options left to get substantially reduced rates increased.

    By July 14, 2021
  • Image attribution tooltip

    iStock

    Telehealth use stabilizing at 38 times pre-COVID-19 levels, McKinsey says

    Although usage has dropped slightly since its peak in spring 2020, patient and physician attitudes toward telehealth have improved, according to new data from the consultancy.

    By Rebecca Pifer • July 13, 2021
  • Image attribution tooltip
    Joe Raedle via Getty Images

    Hillrom ordered to complete BardyDx transaction by Delaware court

    The court found recent Medicare rate cuts for long-term cardiac wearables did not qualify as a material adverse event, siding with Bardy Diagnostics. However, the judge did not grant BardyDx compensatory damages.

    By July 12, 2021
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    MDUFA talks expose 'fundamentally different' views of FDA and device companies

    At the latest meeting over user fees, industry remained opposed to the agency's pitch for a Total Product Life Cycle Advisory Program, which it contends would extend the scope beyond FDA's purview. 

    By July 12, 2021
  • Image attribution tooltip
    Fotolia

    Digital health funding in 2021 smashes last year's record with $14.7B

    Coronavirus-spurred momentum in the sector has only accelerated, according to a new Rock Health report.

    By Rebecca Pifer • July 7, 2021
  • Image attribution tooltip
    Danielle Ternes/MedTech Dive, original photo courtesy of Dexcom
    Q&A

    Dexcom CEO on the Type 2 population, the Super Bowl ad and pandemic momentum

    Kevin Sayer called Type 2 a "tremendous market opportunity" and said direct-to-consumer advertising is worth some controversy.

    By July 6, 2021
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    Neuromodulation and cancer devices feature in latest batch of FDA breakthrough nods

    Neuroelectrics, Neuros Medical and Onward are among those that secured the regulatory privilege, which speeds the review process for unmet medical needs.

    By July 2, 2021
  • Image attribution tooltip
    Retrieved from C-SPAN on February 23, 2021

    Biden admin 'absolutely supportive' of telehealth once crisis ebbs, Becerra says

    The HHS secretary also stressed that, though affordable virtual care should be available to all, the agency would double down to ensure accountability for quality of care.

    By Rebecca Pifer • July 1, 2021
  • Image attribution tooltip
    Kendall Davis/MedTech Dive, original photos courtesy of Abbott and Dexcom

    Roundup: Trial results, looming product releases fuel diabetes tech competition

    In the first half of the year, the space is meeting Wall Street's high expectations for 2021. Here's a roundup of MedTech Dive's coverage of the market, including from this week's American Diabetes Association meeting.

    June 30, 2021
  • Medtronic smart insulin pen improved time in target blood glucose levels: study

    The medtech giant's trial results come as competition in the space is intensifying. Eli Lilly and Bigfoot Biomedical, partnered with Abbott, are also prioritizing the technology.

    By June 29, 2021